Cargando…
Delicaflavone Reverses Cisplatin Resistance via Endoplasmic Reticulum Stress Signaling Pathway in Non-Small Cell Lung Cancer Cells
BACKGROUND: The incidence and mortality of lung cancer continue to increase around the world; in 2018, new lung cancer cases accounted for 11.6% of all cancer cases, and lung cancer deaths accounted for 18.4% of cancer deaths. Cisplatin (DDP) is a first-line chemotherapy drug for lung cancer; howeve...
Autores principales: | Wang, Xuewen, Chen, Bing, Xu, Danfen, Li, Zhijun, Sui, Yuxia, Lin, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568618/ https://www.ncbi.nlm.nih.gov/pubmed/33116611 http://dx.doi.org/10.2147/OTT.S255586 |
Ejemplares similares
-
Delicaflavone Represses Lung Cancer Growth by Activating Antitumor Immune Response through N6-Methyladenosine Transferases and Oxidative Stress
por: Wang, Xuewen, et al.
Publicado: (2022) -
Curcumin Increased the Sensitivity of Non-Small-Cell Lung Cancer to Cisplatin through the Endoplasmic Reticulum Stress Pathway
por: Wang, Lile, et al.
Publicado: (2022) -
Pharmacokinetics, Tissue Distribution, and Human Serum Albumin Binding Properties of Delicaflavone, a Novel Anti-Tumor Candidate
por: Chen, Bing, et al.
Publicado: (2021) -
Astragaloside IV sensitizes non-small cell lung cancer cells to cisplatin by suppressing endoplasmic reticulum stress and autophagy
por: Lai, Song-Tao, et al.
Publicado: (2020) -
Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage
por: Wu, Yuping, et al.
Publicado: (2018)